Rare diseases
Investigational molecules
Locations
Back to Germany1 118 clinical trials in Sankt Augustin, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A study to evaluate the effectiveness and safety of AP707 in patients with borderline personality disorder.
GermanyStudy of asciminib, dexamethasone, blinatumomab, and vincristine sulfate in children and young adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia
GermanyA study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis
GermanyA study to evaluate the safety and effectiveness of PF-08634404 and ipilimumab in adults with advanced or spreading liver cancer
GermanyA study to evaluate the safety and effectiveness of subcutaneous blinatumomab in adults and adolescents with relapsed, refractory, or minimal residual disease positive B-cell precursor acute lymphoblastic leukemia.
GermanyA study to evaluate the safety and effectiveness of ADX-038 in adults with geographic atrophy caused by age-related macular degeneration.
GermanyGermanyA study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis
GermanyA study to evaluate the effectiveness and safety of admilparant in patients with idiopathic pulmonary fibrosis
GermanyPhase 3 Randomized Study of Niraparib Tosilate Monohydrate vs. Temozolomide in Newly Diagnosed MGMT Unmethylated Glioblastoma
GermanyStudy of Izalontamab Brengitecan versus Platinum-based Chemotherapy for Patients with EGFR-mutated Non-small Cell Lung Cancer after EGFR Inhibitor Treatment
GermanyTesting continuous versus intermittent treatment with cetuximab, fluorouracil, folinic acid, and irinotecan in patients with newly diagnosed metastatic colorectal cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on innovative treatments for juvenile arthritis conditions, including studies of medications like baricitinib, ustekinumab, and bimekizumab for various forms of JIA.
Research aims to evaluate drug efficacy and safety in pediatric populations with autoimmune conditions.
Comprehensive studies on childhood cancers, with particular focus on leukemia and lymphoma treatments, including novel therapeutic approaches and combination therapies.
Investigations include targeted therapies and personalized treatment protocols for various cancer stages.
Specialized research into brain and nervous system tumors, focusing on ependymoma and medulloblastoma treatment strategies.
Studies evaluate surgical outcomes, radiation therapy approaches, and chemotherapy effectiveness.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
